NEW YORK (GenomeWeb News) – GlaxoSmithKline has teamed with the European Bioinformatics Institute (EMBL-EBI), the US National Library of Medicine, and informatics provider Collaborative Drug Discovery to freely share the chemical structures of 13,500 molecules from GSK's compound library for malaria research. EMBL-EBI will serve as the primary repository for the data on the compound set.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.